Nisa Investment Advisors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.95K | Sell |
2,612
-673
| -20% | -$761 | ﹤0.01% | 2532 |
|
|
2025
Q1 | $4.8K | Buy |
3,285
+364
| +12% | +$531 | ﹤0.01% | 2266 |
|
|
2024
Q4 | $6.22K | Sell |
2,921
-7,869
| -73% | -$16.8K | ﹤0.01% | 2230 |
|
|
2024
Q3 | $30.2K | Buy |
10,790
+23
| +0.2% | +$64 | ﹤0.01% | 1777 |
|
|
2024
Q2 | $25.1K | Buy |
10,767
+8,734
| +430% | +$20.4K | ﹤0.01% | 1865 |
|
|
2024
Q1 | $9.09K | Buy |
2,033
+13
| +0.6% | +$58 | ﹤0.01% | 2057 |
|
|
2023
Q4 | $6.48K | Sell |
2,020
-80
| -4% | -$257 | ﹤0.01% | 2097 |
|
|
2023
Q3 | $6.66K | Buy |
2,100
+140
| +7% | +$444 | ﹤0.01% | 2248 |
|
|
2023
Q2 | $9.74K | Buy |
1,960
+1,400
| +250% | +$6.96K | ﹤0.01% | 2260 |
|
|
2023
Q1 | $3K | Hold |
560
| – | – | ﹤0.01% | 2272 |
|
|
2022
Q4 | $4K | Sell |
560
-68
| -11% | -$486 | ﹤0.01% | 2304 |
|
|
2022
Q3 | $6K | Buy |
628
+68
| +12% | +$650 | ﹤0.01% | 2262 |
|
|
2022
Q2 | $6K | Hold |
560
| – | – | ﹤0.01% | 2248 |
|
|
2022
Q1 | $5K | Buy |
+560
| New | +$5K | ﹤0.01% | 2304 |
|
|
2021
Q4 | – | Sell |
-560
| Closed | -$14 | – | 2173 |
|
|
2021
Q3 | $14 | Hold |
560
| – | – | ﹤0.01% | 2156 |
|
|
2021
Q2 | $15 | Hold |
560
| – | – | ﹤0.01% | 2171 |
|
|
2021
Q1 | $20 | Hold |
560
| – | – | ﹤0.01% | 2126 |
|
|
2020
Q4 | $14K | Sell |
560
-1,250
| -69% | -$31.3K | ﹤0.01% | 2170 |
|
|
2020
Q3 | $68K | Buy |
1,810
+1,350
| +293% | +$50.7K | ﹤0.01% | 1669 |
|
|
2020
Q2 | $20K | Buy |
+460
| New | +$20K | ﹤0.01% | 1772 |
|